deletion mutation of one of these isoforms, i.e. synaptotagmin I, in transgenic mice or of Drosophila synaptoThe Ca 2⍣ -and phospholipid-binding protein synaptotagmin is involved in neuroexocytosis. Its precise role tagmin, led to a major impairment of fast Ca 2ϩ -induced and Ca 2⍣ -affinity in vivo are unclear. We investigated neuroexocytosis. Nonetheless, the precise role and Ca 2ϩ its putative function in insulin secretion which is affinity in vivo of synaptotagmin I are unknown (DiAntonio maximally stimulated by 10 μM cytosolic free Ca 2⍣ . et al., 1993; Broadie et al., 1994 ; DiAntonio and Schwarz, The well-characterized synaptotagmin isoforms I and 1994; Geppert et al., 1994) .
II are present in pancreatic β-cell lines RINm5F, INS-
Synaptotagmin is an integral membrane protein of 1 and HIT-T15 as shown by Northern and Western synaptic vesicles (Brose et al., 1992) and of neurohormoneblots. Subcellular fractionation and confocal microcontaining secretory vesicles (Walch Solimena et al., scopy revealed their presence mainly on insulin-con-1993). It is composed of a short intravesicular N-terminal taining secretory granules whereas only minor amounts sequence, a single transmembrane region and a large were found on synaptic vesicle-like microvesicles. Anticytosolic portion (Sudhof, 1995) . The main features of bodies or Fab-fragments directed against the Ca 2⍣ -the cytosolic part are two Ca 2ϩ -binding repeats, the C 2 dependent phospholipid binding site of the first C 2 domains, whose basic motif was first identified in protein domain of synaptotagmin I or II inhibited Ca 2⍣ -kinase C and has subsequently been found in several stimulated, but not GTPγS-induced exocytosis from other proteins. They mediate Ca 2ϩ -induced attachment to streptolysin-O-permeabilized INS-1 and HIT-T15 cells.
membrane lipids (Brose et al., 1992) . Several functions Transient expression of wild-type synaptotagmin II have been assigned to the C 2 domains in synaptotagmin. did not alter exocytosis in HIT-T15 cells. However,
The first C 2 domain (C 2 A) binds to phospholipids at mutations in the Ca 2⍣ -dependent phospholipid binding~5 μM free Ca 2ϩ (Brose et al., 1992; Li et al., 1995;  site of the first C 2 domain (Δ180-183, D231S) again Fukuda et al., 1996) and to the membrane protein syntaxin inhibited only Ca 2⍣ -, but not GTPγS-evoked exocytosis.
1 in the presence of several hundred micromolar Ca 2ϩ (Li In contrast, mutations in the IP 4 -binding sites of the et al., 1995) . The latter Ca 2ϩ requirement coincides with second C 2 domain (Δ325-341; K327,328,332Q) did not that for exocytosis in bipolar neurones (Heidelberger et al. , alter exocytosis. Synaptotagmin II mutated in both C 2 1994) . In addition to Ca 2ϩ -sensitive properties, the second domains (Δ180-183/K327,328,332Q) induced greater C 2 domain (C 2 B) binds inositol-1,3,4,5-tetrakisphosphate inhibition than mutant Δ180-183, suggesting a discrete (IP 4 ) independent of Ca 2ϩ . The requirement for the second C 2 domain. Thus, synaptoinjection of IP 4 into a preterminal of the squid giant tagmin isoforms regulate exocytotic events occurring synapse inhibited neuroexocytosis. This effect can be at low micromolar Ca 2⍣ .
Introduction
pancreatic β-cells, is maximally stimulated by 7-10 μM free Ca 2ϩ with an EC 50 of 1.6 μM (Vallar et al., 1987, The secretion of insulin proceeds by exocytosis, i.e. fusion Ullrich et al., 1990 , Bokvist et al., 1995 Proks et al., between secretory granules and plasma membranes with 1996) . β-Cells therefore provide a good model to test the subsequent release of the granule content into the extraaction of synaptotagmin domains in situ at low micromolar cellular space . Exposure of β-cells Ca 2ϩ . Although the occurrence of several synaptotagmin to secretagogues increases the cytosolic Ca 2ϩ to micromolar levels, which in turn triggers insulin secretion isoforms has been described in pancreatic β-cells at the Fig. 1 . RNA blot analysis of synaptotagmin I and II mRNAs in insulin-secreting β-cell lines. 30 μg of total RNA from whole rat brain or indicated cell lines and primary islet cells were denatured and electrophoresed as described in the text. Upper panel, expression of synaptotagmin I RNA; Lower panel, expression of synaptotagmin II RNA. For autoradiography, the nylon membrane was exposed to X-ray film with an intensifying screen at -80°C for 3 days. Arrowheads indicate the position of 18S and 28S RNA. RNA level, their subcellular localization is unresolved PVDF and probed with antibodies against the first C 2 -domain (C 2 A) of (Mizuta et al., 1994; Wheeler et al., 1996) . This is of 
Results
be excluded as mab 8G2b strongly reacted with a 60 kDa band in immunoblots from hamster brain (data not shown). We first investigated the expression and subcellular distribution of synaptotagmin I and II. RNA blot analysis for
We therefore prepared secretory granule membranes and detergent extracts of crude membranes from HIT-T15 synaptotagmin I and II revealed the presence of a 4.8 kb transcript for the synaptotagmin I in rat brain RNA and cells. In those preparations synaptotagmin II is clearly detectable. This isoform is therefore also expressed in this RNA from the insulin-secreting cells RINm5F, HIT-T15 and INS-1 as well as primary islet cells (Figure 1 , upper cell line, albeit at lower levels than in the other insulinsecreting cells. panel). Similarly, a 7 kb band was detected in blots probed for synaptotagmin II (Figure 1 , lower panel) and, in Insulin-secreting cells contain two types of exocytotic vesicles: small synaptic-like mirovesicles, SLMVs (Reetz addition, a minor transcript migrating at~9 kb was apparent. The abundance of mRNAs for synaptotagmin I et al., 1991) and insulin-containing granules. Exocytotic vesicle proteins may be localized on both of them (Regazzi and II was less in insulin-secreting cells as compared with rat. et al., 1995) . Therefore The above results suggested that synaptotagmin I and II are concentrated on insulin-containing secretory panel). The distribution of synaptotagmin I and II was tested with mab 41.1, directed against synaptotagmin I, granules. We have therefore studied whether they could play a functional role in exocytosis, the final step of and with anti-sytI/II, which recognizes synaptotagmin I and II. As indicated in Figure 3 (upper panel), immunoinsulin secretion. To this end we initially used two antibodies which bind to defined regions of synaptotagmin. reactivity for synaptotagmin I and II was mainly concentrated in the fractions 12-15 containing secretory granules.
Affinity-purified anti-sytI/II binds to the first C 2 domain (C 2 A) of synaptotagmin and inhibits Ca 2ϩ -dependent interIn contrast, only a small amount of immunoreactivity was found in the synaptophysin-reactive fractions 5 and 6 action of synaptotagmin II with phospholipid vesicles (Fukuda et al., 1995a; Mikoshiba et al., 1995) . The containing SLMVs. In addition, some synaptotagmin immunoreactivity sedimented in a region previously identimonoclonal antibody mab 41.1 has been shown to require a short stretch of nine amino acids in the C 2 A domain of fied as containing plasma .
The subcellular distribution of synaptotagmin in INS-1 synaptotagmin I for binding (Chapman and Jahn, 1994) and these amino acids are required for Ca 2ϩ -dependent cells was further examined by histocytochemistry and confocal microscopy ( Figure 4 ). The upper panel demoninteraction with phospholipid vesicles (Chapman and Jahn, 1994; Fukuda et al., 1996) . In the upper panel of Figure  strates that insulin and synaptophysin-markers for secretory granules and synaptic-like microvesicles, 5, the isoform specificity of these two antibodies is illustrated from experiments with recombinant fusion respectively-do not co-localize. As already observed in subcellular fractionation, synaptotagmin does stain proteins. Both antibodies interacted with the first C 2 domain (sytI-C 2 A), but not with the second C 2 domain of synaptophysin-positive structures (Figure 4) . A different situation was encountered in the co-staining for insulin synaptotagmin I (sytI-C 2 B). Anti-sytI/II reacted equally well with synaptotagmin II, but none of the two antibodies (green) and synaptotagmin (red) ( Figure 4B ). Synaptotagmin was found in a granular pattern and outlining the recognized synaptotagmin III, synaptotagmin IV or GST alone, the tag of the fusion protein.
To test the functional cell surface. Most of the immunoreactivity for insulin colocalizes with synaptotagmin, as indicated by the yellow activity of the antibodies, INS-1 or HIT-T15 cells were permeabilized with streptolysin-O (SL-O) and substain. A similar co-localization between synaptotagmin and insulin, but not with synaptophysin, was observed in sequently preincubated at 0.1 μM Ca 2ϩ with the indicated concentration of affinity-purified IgG (anti-sytI/II) or Fab-HIT-T15 cells (data not shown). Immunocytochemistry on pancreatic islets extended previous observations for fragments of mab 41.1 (Fab 41.1) as shown in Figure 5 (lower panel). After aspiration of antibody solutions, cells synaptotagmin I (Jacobsson et al., 1994) to synaptotagmin II. Immunoreactivities for both isoforms were absent from were exposed to basal levels of free Ca 2ϩ (0.1 μM), or maximally stimulatory levels of Ca 2ϩ (10 μM) as preprimary β-cells but were found on non-insulin endocrine islet cells (data not shown).
viously demonstrated for β-cells and derived cell lines ( Vallar et al., 1987; Ullrich et al., 1990; Ammala et al., et al., 1994; Kiraly-Borri et al., 1996) . The difference between insulin release at basal Ca 2ϩ conditions and at 1993; Bokvist et al., 1995) . Alternatively, cells were stimulated with GTPγS. This stable GTP analogue induces stimulatory conditions (10 μM Ca 2ϩ , 100 μM GTPγS) in the absence of antibodies was normalized to 100%. In Ca 2ϩ -independent exocytosis (Vallar et al., 1987; Jonas both cell lines, HIT-T15 and INS-1, the Fab-fragment and cells permeabilized by Staphylococcus aureus α-toxin (Table I) . This toxin produces only small pores in the the affinity-purified IgG inhibited Ca 2ϩ -evoked insulin plasma membrane which do not allow the entry of molerelease by~60%, whereas the GTPγS-induced release cules larger than 0.5-2 kDa. The inefficacy of the specific remained unchanged ( Figure 5 , lower panel). In contrast antibodies in α-toxin-permeabilized cells also excludes to the inhibitory action of native Fab 41.1 or anti-sytI/ any contribution by antibody buffers to the inhibitory II IgG, preheated preparations were inactive (Table I) .
effect observed in SL-O-permeabilized cells. Furthermore, control IgG or Fab did not alter insulin These results suggest a specific role for the C 2 A domain release, and a monoclonal antibody against the intravesicuof synaptotagmin I in Ca 2ϩ -stimulated exocytosis from lar N-terminus, which is located inside the secretory insulin-secreting cells. As the functional antibody antigranule, did not affect hormone levels. A possible effect sytI/II reacted with both isoforms-that is, synaptotagmin of Fab 41.1 or anti-sytI/II IgG on the cell surface could I and II-we used a separate approach to evaluate further be excluded as Fab fragments or IgG were inactive in the role of synaptotagmin II in the secretion of insulin. In HIT-T15 cells we transiently expressed wild-type synaptotagmin II or synaptotagmin II mutated in the C 2 domains.
To determine the subcellular localization of transiently expressed synaptotagmin II, we analysed its distribution by confocal microscopy. Thus, we took advantage of the finding that only low endogenous levels of synaptotagmin II are present in HIT-T15 cells (see also Figure 2 ). Therefore, a monoclonal antibody could be used that is directed against the N-terminus which is highly isoform-specific (Li et al., 1995) . At the dilution used, the antibody did not react with endogenous synaptotagmin II (data not shown). Transiently expressed synaptotagmin II again co-localized largely with secretory granules as indicated by the co-distribution of insulin ( Figure 6 ). In addition, synaptotagmin immunoreactivity was observed on the cell border ( Figure 6 ) similar to endogenous synaptotagmin in INS-1 cells (see Figure 4) . Table I . n ϭ 6-21 from at least three separate experiments for each point; *, 2P Ͻ0.05.
fluorescence-activated cell sorting. As shown in the upper Cells were permeabilized with streptolysin-O or with α-toxin and pretreated with IgG (anti-sytIIC2A, mab 604.4, non-specific IgG, 40 μg/ml) or Fab-fragments (Fab 41.1, non-specific Fab, 40 μg/ml) as in Figure 6 . Heat inactivation of antibodies was performed for 20 min at 60°C. Cells were subsequently exposed to 0.1 μM Ca 2ϩ , 0.1 μM Ca 2ϩ with 100 μM GTPγS (GTPγS) or 10 μM Ca 2ϩ for 7 min and insulin release determined in the supernatants. Values are expressed as percent of controls (0.1 μM Ca 2ϩ in the absence of IgG or Fab) and means Ϯ SEM are given for n ϭ 6-9 from three separate experiments; *, 2P Ͻ0.05; n.d., not determined. panel of Figure 7 , again using a monoclonal antibody mimic binding of the C 2 B domain of synaptotagmin to membranes (Llinas et al., 1994; Mochida et al., 1997) . In specific for synaptotagmin II , wildtype protein and its different mutants were expressed at our hands these mutants did not alter the secretion of insulin. However, a double mutant (DM) containing Δ180-comparable levels.
To study the role of synaptotagmin II in secretion and 183 and KQ mutations of the C 2 A and C 2 B domains inhibited the release to a much larger extent than any exocytosis, the GFP-encoding plasmid was replaced by a construct expressing human preproinsulin, and human mutation in the C 2 A domain alone (Figure 7 ). To study whether the observed effects of synaptotagmin II mutants insulin C-peptide release was measured from hamster HIT-T15 cells (Figure 7, lower panel) . This approach reliably on secretion occur at the level of exocytosis, or occur indirectly, we also measured their effect in SL-O-permereflects release from co-transfected cells as published previously . Wild-type synaptotagmin abilized cells. As shown in Figure 8 , under this condition the effects of all tested constructs were comparable with II (wt) did not alter basal insulin release from intact cells or hormone release induced by stimulation due to those observed in intact cells. Similar to the effect of the functional antibodies, again only the Ca 2ϩ -, but not the depolarization of membrane potential by KCl leading to Ca 2ϩ entry through voltage-dependent Ca 2ϩ channels GTPγS-stimulated exocytosis, was affected. (Wollheim and Sharp, 1981; Wollheim et al., 1996) . Deletion mutation Δ180-183 and the point mutation Discussion D231S in the C 2 A domain of synaptotagmin II have been shown to inhibit Ca 2ϩ -dependent phospholipid binding Exocytosis from pancreatic β-cells shares a number of features with exocytosis in neurones and neuroendocrine (Fukuda et al., 1996) . Here they significantly reduced stimulated insulin secretion by some 50% and 35%, cells. We and others have previously shown that the release of insulin involves essential components of the respectively (Figure 7, lower panel) . Two mutations in the C 2 B domain, i.e. Δ325-341 or the exchange of general docking and fusion machinery. The process is ATP-dependent (Vallar et al., 1987; Lang et al., 1995) K326,327,332, to Q (KQ) , abolishes the binding of IP 4 and other inositol high-polyphosphates to synaptotagmin and requires the SNARE proteins synaptobrevin/VAMP , SNAP-25 (Sadoul et al., II (Fukuda et al., 1995a) , a process which is thought to surfaces. Indeed, the synaptic vesicle protein synapto-K327,328 and 332 were exchanged for Q) or in both domains (double brevin/VAMP-2 is distributed equally between the two mutant DM carrying the mutations Δ180-183 and the exchange of K327,328,332 to Q). Secretion experiments were performed 48-72 h vesicle types . The location of later using Krebs-Ringer buffer with 3.4 mM KCl (BASAL) or with synaptotagmin I on peptide hormone vesicles had been 50 mM KCl (50 mM KCl). Subsequently, the amount of human previously established in neuroendocrine cells, although insulin C-peptide in the supernatants was measured reflecting the its relative distribution was not compared with that on secretion from co-transfected cells only. n ϭ 12-24 from at least three separate experiments for each point; *, 2P Ͻ0.05.
other vesicle types (Walch Solimena et al., 1993) . Our findings suggest either the presence of other synaptotagmin isoforms on SMLVs-for example synaptotagmin III 1995) , syntaxin (Martin et al., 1995 (Martin et al., , 1996 and α-SNAP (Kiraly-Borri et al., 1996) . Insulin release is maximal at (Mizuta et al., 1994) -or the possibility that only a fraction of these synaptophysin-positive microvesicles undergoes low micromolar free Ca 2ϩ (Vallar et al., 1987; Ullrich et al., 1990; Bokvist et al., 1995; Proks et al., 1996) . Ca 2ϩ -dependent exocytosis. In addition to their vesicular localization, synaptotagmin I and II were also distributed Therefore, insulin-secreting cells provide a suitable system to test the Ca 2ϩ -dependency of putative Ca 2ϩ -sensing on the plasma membrane, as reported for chromaffin cells 
and neurones (Takahashi et al., proteins in vivo.
Here, we demonstrate that the neuronal Ca 2ϩ -sensing 1991). In neurones, the appearance of synaptotagmin on the cellular surface is linked to stimulation of exocytosis proteins synaptotagmin I and II (Geppert et al., 1991 (Geppert et al., , 1994 , are expressed in pancreatic β-cell lines: they are (Matteoli et al., 1992) , which is followed by rapid endocytosis. As the secretory rate is lower in pancreatic β-cells mainly localized on secretory granules and are implicated in the exocytosis of insulin. As already suggested by the and exo-and endocytosis are less tightly coupled when compared with neurones (Bokvist et al., 1995;  Proks first report on synaptotagmin I , expression is low as compared with neuronal or neuroendoet al., 1996) , the presence of synaptotagmin on plasma membranes most probably reflects a slower turnover of crine cells and may explain previously reported negative findings (Jacobsson et al., 1994; Mizuta et al., 1994;  the protein, thereby leading to its prolonged persistence. The function of synaptotagmin I has been extensively Wheeler et al., 1996) . This scarcity may reflect the lower number of insulin-containing granules in β-cells (Dean, studied in neuroexocytosis (Sudhof, 1995) , which requires levels of free Ca 2ϩ of one to two orders of magnitude 1973; Asfari et al., 1992) as compared with exocytotic vesicles in chromaffin cells (Burgoyne et al., 1982) . The higher than those observed during the exocytosis of insulin (Heidelberger et al., 1994; Heinemann et al., 1994) . Mice subcellular distribution of synaptotagmin I and II is remarkable. The pancreatic β-cells contain two types of and Drosophila exhibit a lethal phenotype after mutation of synaptotagmin I or Drosophila syt gene and selective exocytotic vesicles, i.e. the insulin granule and SLMVs. The latter are characterized by the presence of synaptoimpairment of Ca 2ϩ -dependent neurotransmitter release (DiAntonio et al., 1993; Broadie et al., 1994 ; DiAntonio less tightly coupled to Ca 2ϩ entry sites in β-cells than in neuronal systems (Bokvist et al., 1995) . Our results suggest and Schwarz, 1994; Geppert et al., 1994) . In neuroendocrine PC12 cells the injection of Fab-fragments directed that two synaptotagmin isoforms, synaptotagmin I and II, fulfil rather similar roles in insulin exocytosis in terms of against synaptotagmin I inhibits regulated exocytosis (Elferink et al., 1993) . In conjunction with the known Ca 2ϩ -dependent phospholipid binding by the C 2 A domain. In contrast to the role of the C 2 A domain, we did not biochemical characteristics of synaptotagmin I (Chapman and Jahn, 1994; Li et al., 1995; Sudhof, 1995; Sugita find clear evidence for the function of the IP 4 -binding site of the C 2 B domain in endocrine exocytosis. , these reports demonstrate that this protein may serve as an exocytotic Ca 2ϩ -sensor. Our study has demonstrated by genetic analysis in Drosophila, the C 2 B domain is necessary for correct function of synaptotagmin addressed the role of Ca 2ϩ -dependent and -independent phospholipid binding to C 2 A or C 2 B domains in endocrine (DiAntonio and Schwarz, 1994) . In addition, a role for the IP 4 -binding site in C 2 B has previously been indicated exocytosis by the use of functional antibodies and mutants of synaptotagmin II. Both antibodies have previously been by the injection of peptides (Bommert et al., 1993) or inositol high-polyphosphates (Llinas et al., 1994 ; Fukuda shown to inhibit Ca 2ϩ -dependent phospholipid binding and neuroexocytosis from squid giant synapse (Mikoshiba et al., 1995b) into squid giant presynaptic terminals. However, more detailed investigation suggested that the et al. , 1995) and chromaffin cells (Ohara Imaizumi et al., 1997) or to interact with an epitope on synaptotagmin main function of the IP 4 -binding site in the C 2 B domain involves recycling via endocytosis as shown in superior required for this function (Chapman and Jahn, 1994) . The inhibition observed here was specific for the antibodies cervical ganglion cells (Mochida et al., 1997) . Our negative results are therefore not surprising in view of the differand selective for Ca 2ϩ -dependent exocytosis not affecting stimulation with GTPγS. Similar results were obtained ences between synaptic vesicle and secretory granule biogenesis (Bauerfeind and Huttner, 1993) . It should also with mutations of synaptotagmin II C 2 A domain deficient in Ca 2ϩ -dependent phospholipid binding (Δ181-183, be pointed out that our biochemical assay of exocytosis does not discern rapid kinetic changes. D231S) (Fukuda et al., 1996) , which produced a dominant negative phenotype on overexpression in HIT-T15 cells.
Exocytosis of insulin can be triggered reversibly by either Ca 2ϩ or in a Ca 2ϩ -independent fashion by GTP and The epitope recognized by Fab 41.1 and the deletion mutation SytIIΔ181-183 probably do not interfere with its more stable analogue GTPγS (Vallar et al., 1987 , but differ in their kinetics and requirements for cytosolic factors (Jonas et al., 1994; synaptotagmin I (Chapman and Jahn, 1994) , corresponding to amino acids 178-186 in synaptotagmin II (Geppert Kiraly-Borri et al., 1996; Proks et al., 1996) . The selective alteration of Ca 2ϩ -triggered exocytosis found here underet al., 1991) . The deletion mutant synaptotagmin IΔ177-185 no longer binds the antibody, whereas Ca 2ϩ -dependent scores the specificity of the methods employed and adds to the previously described differences between the two binding to syntaxin is not altered (Chapman et al., 1995) . Our functional data thus clearly demonstrate that phosphostimuli. As activation of a GTP-binding protein is required for Ca 2ϩ -stimulated exocytosis of insulin (Vallar et al., lipid binding by the C 2 A domain previously found in biochemical assays is required for Ca 2ϩ -stimulated endo-1987; Proks et al., 1996) , the GTPase may intervene between the Ca 2ϩ targets, such as synaptotagmin, and crine exocytosis. This provides an indication for the role of synaptotagmin II. The Ca 2ϩ -dependency of this membrane fusion itself. However, more detailed studies are clearly required to elucidate the exact organization of phospholipid-binding step as characterized with recombinant or native proteins coincides well with the concentration the two intertwining stimulatory pathways in exocytosis.
In conclusion, our data demonstrate that synaptotagmin range of free Ca 2ϩ occurring in endocrine exocytosis, i.e. between 1 and 10 μM (Vallar et al., 1987; Ullrich et al., function is implicated in endocrine exocytosis, a process being maximal at 7-10 μM Ca 2ϩ . Furthermore, this 1990; Bokvist et al., 1995; Proks et al., 1996) .
It is still unclear whether all the biochemically characterinvolves the well-known capacity of synaptotagmin to bind phospholipids. This characterizes synaptotagmin as ized activities of synaptotagmin participate in exocytosis. A sequential model has been proposed (Chapman et al., aCa 2ϩ sensor in regulated endocrine exocytosis from the pancreatic β-cells. 1996) to account for the described high and low Ca 2ϩ affinities on the one hand (phospholipid binding, oligomerization and syntaxin binding) and the Ca 2ϩ require-
Materials and methods
ments of exocytosis as in retinal bipolar neurones on the other (Heidelberger et al., 1994) . It has been suggested Materials that synaptotagmin binding to syntaxin may serve for coRecombinant streptolysin-O (SL-O) was produced in Escherichia coli. The cDNAs encoding for the C 2 A or the C 2 B domain of synaptotagmin localization of fusion sites with Ca 2ϩ entry (Leveque et al., I (Elferink et al., 1993) were kindly provided by Dr R.Scheller (Stanford, 1994) . The Ca 2ϩ levels described for effective interaction USA) . The cloning of synaptotagmin II and the construction of the with syntaxin (0.1-1 mM) do not occur in pancreatic β mutants used have been described previously (Fukuda et al., 1995a) . cells and derived cell lines (Theler et al., 1992; Bokvist The following monoclonal antibodies were generously donated to us: mab 604.1 and mab or Fab 41.1 (Dr R.Jahn, New Haven, CT), mab et al., 1995) . Therefore, either still unknown additional with secretion assays suggest that secretory granules are cells were cultured on microwells coated with fibroblast matrix (ELDANStatistical analysis Results are presented as mean Ϯ SEM from experiments performed Tech, Jerusalem, Israel) to ensure persistent cell attachment during the independently on at least three different cell preparations, unless stated permeabilization with streptolysin-O. For transient co-transfection all otherwise. Statistical analysis was performed by Student's two-tailed constructs have been subcloned into pCDNA3 (Invitrogen, San Diego, t-test for unpaired data (2P). CA). HIT-T15 cells were transiently co-transfected as published except for the use of 1 μl of Transfectam and 5 μg of plasmid per well (2.5 μg phINS encoding for human insulin, 1.25 μg
